Among biologics used for treating psoriasis, there do not appear to be differential risks for serious infection or respiratory tract infection, according to a study presented at the annual meeting of the European Academy of...
Read MoreThe first interchangeable biosimilar product to Humira (adalimumab) was approved by the FDA in October, the agency announced. Cyltezo (adalimumab-Adam), originally approved in 2017 for multiple chronic inflammatory diseases, is...
Read More
“eHealth devices are becoming increasingly popular among dermatologists and their patients,”...
Read MoreDuring a recent PW Podcast, Rachel Giles, MD, from Medicom Medical Publishers, spoke with Graham McMahon, MD, MMSc, President and Chief Executive Officer of the Accreditation Council for Continuing Medical Education (ACCME)...
Read MoreThis article originally appeared on KevinMD.com and is written by Taison Bell, MD. Dear pharmacist, You just paged me and, I must admit, I’m not feeling excited to call back. I estimate that I probably get paged, called, texted,...
Read More
